Rappahannock News

COVID-19 vaccines for most Rapp residents not likely until spring

Drive-through inoculatio­ns at fire and rescue stations a possible option

- BY RANDY RIELAND For Foothills Forum

There was much to celebrate earlier this week when hospital workers around the country began receiving inoculatio­ns that should protect them from the pandemic that’s killed more than 300,000 Americans.

But the next phase of the process — making the vaccine more widely available in a systematic and even-handed manner — is, in its own way, equally complex and challengin­g.

The CDC’s Advisory Committee on Immunizati­on Practices set things in motion last weekend by recommendi­ng that healthcare workers and residents of long-term care facilities be given top priority for getting vaccine shots.

Boxes of Pfizer's vaccine began arriving in hospitals in the region this week, and next week teams from CVS

and Walgreens are expected to start vaccinatin­g residents of nursing homes.

But how “healthcare workers” is de ned has been le up to each state, and in Virginia it covers a wide range. While hospital workers are at the top of the list, the “healthcare” group also includes people who could directly interact with known or suspected COVID-19 patients, such as Emergency Medical Services (EMS) and dialysis center personnel, and also those who see patients who aren’t known to be infected. That includes primary care physicians and dentists, and the people in their o ces, who come in contact with patients.

Following them on the priority list are “essential workers” and “high-risk adults,” neither of which has yet been delineated.

In this region, the job of getting the vaccine to those groups, and ultimately to the general public, will largely fall to the Rappahanno­ck-Rapidan Health District (RRHD), which serves Rappahanno­ck, Fauquier, Culpeper, Madison and Orange counties.

“We’re having discussion­s now on how this will be coordinate­d,” said Dr. Wade Kartchner, RRHD’s health director. “It’s a challenge for every health district in the state.”

At least initially, those e orts will be constraine­d by how much vaccine is made available. Virginia hopes to have 480,000 doses delivered by the end of the year — although that remains a moving target — and each person will need to receive two doses 21 days apart.

That would include the vaccine developed by Moderna, which is expected to receive emergency approval from the Food and Drug Administra­tion shortly. An advantage Moderna’s vaccine has over the one produced by P zer is that it doesn’t have to be stored in ultra-cold freezers and it doesn’t need to be diluted rst.

“As we get vaccines we will distribute it to the priority groups as quickly and e ciently as we possibly can,” said Kathy Hatter, RRHD’s local health emergency coordinato­r. She said it’s still not known how many doses the RRHD will receive by the end of the year.

Despite the multiple layers of distributi­on, Hatter is con dent the RRHD will be able to facilitate vaccinatio­ns for healthcare profession­als outside of hospitals. “We have distributi­on lists for these healthcare providers,” she said. “These are people we work with in our counties all the time.”

Hatter has also begun having weekly virtual meetings with local o cials in the region, including County Administra­tor Garrey W. Curry, to keep them up to speed with the still evolving guidelines from the CDC and the Virginia Department of Health.

It’s not likely that a COVID vaccine will be available to the general public until at least next spring. How it’s distribute­d in a community like Rappahanno­ck has not been determined, although one option could be drive-through inoculatio­ns at re and rescue stations.

Until then, a lot of focus will be on educating people about the e cacy and safety of the approved vaccines. In clinical trials, some people did experience side e ects, such as fatigue, headaches, muscle and joint pain and swelling at the site of the injection. Also, two British health workers who received the P zer vaccine last week had an allergic reaction. But this past weekend, the CDC said people who have su ered allergic reactions to other vaccines could still get a COVID inoculatio­n, although they should be monitored for 30 minutes a erward.

The education campaign will also work to debunk the false myths about COVID vaccinatio­ns. One bogus claim, for instance, is that the vaccine can actually cause the coronaviru­s; another that the shots can alter a person’s DNA.

Health o cials will likewise emphasize the need to keep up the precaution­s of mask-wearing and social distancing in the coming months. They worry that the approval of vaccines will make people think the pandemic is fading fast.

“I certainly would encourage people to continue taking precaution­s through getting the vaccine,” Kartchner said. “It makes no sense to let your guard down beforehand, and I suspect we’re going to do so for even a few months a erwards before we see the e ects of the vaccine in the community.”

Dr. Je rey Feit, vice president of population health for Valley Health, agreed.

“What makes me anxious is that everybody’s tired,” he said. “If we see another big spike a er Christmas and New Year’s, we’re going to test our limits prior to getting to the nish line.

“I can’t emphasize enough the importance of doing the simple things. Wearing a mask. Keeping your distance. We need to keep doing the right thing for the next couple of months to get us to the vaccine.

“Take care of yourself. Take care of your family. Take care of your community.”

Boxes of Pfizer's vaccine began arriving in hospitals in the region this week, and next week teams from CVS and Walgreens are expected to start vaccinatin­g residents of nursing homes.

Newspapers in English

Newspapers from United States